Drug Discoverybriefings.

Abstract image of a molecular structure connected by glowing data pathways to laboratory equipment, symbolizing AI-driven drug discovery and data provenance.

AI-Native Drug Discovery Needs Provenance Records, Not Just Speed

As generative AI moves into candidate generation and synthesis, sponsors must build data lineage and model audit trails before IND filing, not after.

Robotic lab arms filling many vials at speed while a lone scientist inspects a single vial under a spotlight in the distance.

The New Bottleneck in AI Drug Discovery Isn't the Model

AI now generates drug candidates faster than labs can validate them, shifting the real constraint from computation to evidence infrastructure and market access.

Abstract image of diverse translucent human silhouettes woven with DNA strands, symbolizing demographic representation gaps in AI-driven drug discovery.

The Subgroup Blind Spot in Drug Discovery AI

As AI compresses drug discovery timelines, unrepresentative training data is emerging as a distinct liability separate from model performance or speed gains.